{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
fludrocortisone acetate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
21 CFR 338
(2017)
Source URL:
First approved in 1955
Source:
NDA202100
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1950
Source:
NDA007073
Source URL:
Class:
POLYMER
Cellacefate is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations. Cellacefate's use in enteric coatings allows tablets to remain intact in the unfavorable gastric acid secretion of the stomach, but dissolve in the more basic areas of the duodenum, thus protecting the stomach from ulceration or allowing greater absorption form the duodenum. Cellacefate is a reaction product of phthalic anhydride and a partial acetate ester of cellulose.
Status:
Possibly Marketed Outside US
Source:
ANDA091135
(2012)
Source URL:
First approved in 1948
Source:
NDA018279
Source URL:
Class:
POLYMER
Status:
US Approved OTC
Source:
21 CFR 346.18(b) anorectal:astringent witch hazel (haramelis water)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03371381: Phase 1/Phase 2 Interventional Terminated Adenocarcinoma of Lung
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(18)(ii) skin protectant:astringent clove oil
Source URL:
First approved in 1994
Source:
LEG TIGHTENER by JACKS MFG INC
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Oil of Lemon U.S.P.
(1921)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Oil of Lavender U.S.P.
(1921)
Source URL:
First marketed in 1921
Source:
Oil of Lavender U.S.P.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
